CytoDyn Inc (OTCMKTS:CYDY) Stock On Watchlist Following Major Update

May 25, 2023

If you are currently looking into biotech stocks then it may be a good time to start tracking the CytoDyn Inc (OTCMKTS:CYDY) stock. The company is currently involved in the development of leronlimab, a product that could have a range of therapeutic indications. Trading Data On Wednesday, CYDY stock gained 0.87% to $0.2620 with more than 523.96K shares, compared to its average volume of 1.40 million shares. The stock moved…


CytoDyn Inc (OTCMKTS:CYDY) Stock Continues to Trend Lower: Here is Why

July 12, 2022

Clinical stage biotech company CytoDyn Inc (OTCMKTS:CYDY) suffered in the markets on Monday as its stock suffered from a selloff and ended the day with a decline of as much as 10%. If a stock falls as sharply, it may be a good move for investors to work out if the decline in the stock is going to continue or if it might make a rebound any time soon. In…


CytoDyn Inc (OTCMKTS:CYDY) Announces Multiple Scientific Board of Advisors: Stock Gains

May 16, 2022

There were a number of stocks which had managed to clock notable gains this past Friday and one of those was the CytoDyn Inc (OTCMKTS:CYDY) stock, which ended up with gains of as much as 13%. Trading Data On Friday, CYDY stock surged 12.40% to $0.34 with more than 1.90 million shares, compared to volume of 2.44 million shares. The stock moved within a range of $0.2951 – 0.3700 after…